Gene: ZNF641
Official Full Name: zinc finger protein 641provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in cytosol; nucleolus; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29618 | ZNF641 Knockout cell line (HeLa) | Human | ZNF641 | 1:3~1:6 | Negative | Online Inquiry |
KO29619 | ZNF641 Knockout cell line (HCT 116) | Human | ZNF641 | 1:2~1:4 | Negative | Online Inquiry |
KO29620 | ZNF641 Knockout cell line (HEK293) | Human | ZNF641 | 1:3~1:6 | Negative | Online Inquiry |
KO29621 | ZNF641 Knockout cell line (A549) | Human | ZNF641 | 1:3~1:4 | Negative | Online Inquiry |
ZNF641 Gene Knockout Cell Lines represent a cutting-edge biological research tool that enables scientists to investigate the functional role of the ZNF641 gene in various cellular processes. These specialized cell lines have been genetically engineered to lack the ZNF641 gene, allowing researchers to study the resulting phenotypic changes and elucidate the gene's contribution to cellular mechanisms such as transcriptional regulation, apoptosis, and cellular differentiation.
The ZNF641 gene encodes a zinc finger protein that is implicated in various biological functions, including development, immune response, and disease pathogenesis. By utilizing the knockout cell lines, researchers can assess the disruptions in cellular signaling pathways and gene expression profiles that occur in the absence of ZNF641. This insight is crucial for understanding its role in conditions such as cancer and neurodegenerative diseases, where ZNF641 may play a significant part in disease progression.
One of the key advantages of our ZNF641 Gene Knockout Cell Lines is the precision and reliability achieved through state-of-the-art CRISPR-Cas9 gene editing technology. This ensures that the knockout is not only effective but also reproducible across different experimental settings. Compared to alternative methods, our knockout cell lines provide a more efficient and ethical approach, eliminating the need for time-consuming animal studies while still delivering domain-specific insights.
Researchers and clinicians will find these cell lines indispensable for high-throughput screening assays, drug discovery, and functional genomics studies. The ability to decode the functional landscape of ZNF641 can lead to novel therapeutic strategies and biomarker identification, ultimately enhancing our understanding of complex biological systems.
With a robust portfolio in genetic engineering and a commitment to advancing biological research, our company offers unparalleled expertise and support for researchers seeking to explore the cutting-edge of gene function and regulation. The ZNF641 Gene Knockout Cell Lines therefore stand as a testament to our dedication to providing valuable tools that facilitate innovative discoveries in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.